HomeInsightsStock Comparison

Alpa Laboratories Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Alpa Laboratories Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Alpa Laboratories Ltd is ₹ 103.25 as of 16 Jul 15:30.
  • The P/E Ratio of Alpa Laboratories Ltd changed from 9 on March 2023 to 10.4 on March 2022 . This represents a CAGR of 2.93% over 5 yearsThe P/E Ratio of Sandu Pharmaceuticals Ltd changed from 33.3 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Alpa Laboratories Ltd changed from ₹ 113.15 crore on March 2023 to ₹ 146.23 crore on March 2022 . This represents a CAGR of 5.26% over 5 yearsThe Market Cap of Sandu Pharmaceuticals Ltd changed from ₹ 50.43 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Alpa Laboratories Ltd for the Mar '25 is ₹ 42.4 crore as compare to the Dec '24 revenue of ₹ 34.95 crore. This represent the growth of 21.32% The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore. This represent the decline of -23.15%.
  • The ebitda of Alpa Laboratories Ltd for the Mar '25 is ₹ 2.67 crore as compare to the Dec '24 ebitda of ₹ 9.54 crore. This represent the decline of -72.01% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore. This represent the decline of -49.02%.
  • The net profit of Alpa Laboratories Ltd changed from ₹ 3.03 crore to ₹ -2.12 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.11 crore to ₹ 0.33 crore over 8 quarters. This represents a CAGR of 73.21% .
  • The Dividend Payout of Alpa Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 52.93 % on March 2024 . This represents a CAGR of 9.86% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alpa Laboratories Ltd

  • M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations.
  • In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of 'Alpa Laboratories Limited'.
  • The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh.
  • The unit commenced commercial production in the year 1999 of all types of formulations viz.
  • Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams.

About Sandu Pharmaceuticals Ltd

  • Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
  • The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
  • This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
  • Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
  • Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

Alpa Laboratories Ltd News Hub

News

Alpa Laboratories to discuss results

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 28 May 2...

Read more

19 May 2025 12:01

News

Alpa Laboratories schedules board meeting

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 13 Febru...

Read more

04 Feb 2025 16:36

News

Alpa Laboratories to convene board meeting

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

08 Nov 2024 19:45

News

Alpa Laboratories Ltd leads gainers in 'B' group

Vaswani Industries Ltd, FCS Software Solutions Ltd, Meera Industries Ltd and Zee Media Cor...

Read more

27 Sep 2024 12:15

News

Alpa Laboratories to conduct AGM

Alpa Laboratories announced that the Annual General Meeting (AGM) of the company will be h...

Read more

19 Sep 2024 10:06

News

Alpa Laboratories to convene board meeting

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

05 Aug 2024 14:29

Sandu Pharmaceuticals Ltd News Hub

News

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

29 May 2025 10:50

News

Sandu Pharmaceuticals to table results

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 M...

Read more

19 May 2025 10:56

News

Sandu Pharmaceuticals to convene board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 F...

Read more

05 Feb 2025 12:52

News

Sandu Pharmaceuticals declare Quarterly Result

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 N...

Read more

05 Nov 2024 13:43

News

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

13 Aug 2024 09:53

News

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company ...

Read more

13 Aug 2024 09:53

SWOT Analysis Of Alpa Laboratories Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sandu Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alpa Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd

Which company has a larger market capitalization, Alpa Laboratories Ltd or Sandu Pharmaceuticals Ltd?

Market cap of Alpa Laboratories Ltd is 217 Cr while Market cap of Sandu Pharmaceuticals Ltd is 49 Cr

What are the key factors driving the stock performance of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd?

The stock performance of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd?

As of July 16, 2025, the Alpa Laboratories Ltd stock price is INR ₹103.25. On the other hand, Sandu Pharmaceuticals Ltd stock price is INR ₹51.5.

How do dividend payouts of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd compare?

To compare the dividend payouts of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions